Alkido Pharma Inc. (AIKI) |
|
0.8772 -0.101 (-10.33%)
|
08-13 16:00 |
|
Open: |
0.9698 |
Pre. Close: |
0.9782 |
|
High:
|
0.97 |
Low:
|
0.8745 |
|
Volume:
|
2,884,239 |
Market Cap:
|
31M |
|
|
|
|
AIkido Pharma Inc., a biotechnology development company, focuses on developing small-molecule anti-cancer therapeutics. The company engages in the development of therapeutic drugs for the treatment of pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Its portfolio includes KPC-34 for the treatment of AML and ALL; and DHA-dFdC drug for the treatment of pancreatic cancer. AIkido Pharma Inc. has an artificial intelligence and machine learning research agreement with Cogia Biotech LTD. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2020. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.971 - 0.979 |
0.979 - 0.984 |
|
Low:
|
0.855 - 0.863 |
0.863 - 0.868 |
|
Close:
|
0.869 - 0.882 |
0.882 - 0.89 |
|
Technical analysis |
as of: 2020-08-13 4:31:23 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time. |
| Target: |
Six months: 1.36 One year: 1.62 |
| Support: |
Support1: 0.80 Support2: 0.67 |
| Resistance: |
Resistance1: 1.16 Resistance2: 1.39 |
| Pivot: |
1.11  |
| Moving Average: |
MA(5): 1.06 MA(20): 1.12
MA(100): 0.82 MA(250): 1.21 |
| MACD: |
MACD(12,26): 0.03 Signal(9): 0.06 |
| Stochastic oscillator: |
%K(14,3): 8.99 %D(3): 27.48 |
| RSI: |
RSI(14): 39.06 |
| 52-week: |
High: 2.74 Low: 0.48 Change(%): -58.1 |
| Average Vol(K): |
3-Month: 469850 10-Days: 316271 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.AIKI has closed below the lower band by 18.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 20.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 11 Aug 2020
AIkido Pharma Inc. Extends Option Agreement; The Fundamental Debate on (AIKI) - friscoherald.com
Fri, 07 Aug 2020
Bulls Are Starting To Focus In On AIkido Pharma Inc. (AIKI) - Invest Million
Fri, 07 Aug 2020
AIkido Pharma Inc. (AIKI) is on the roll with an average volume of 4.53M in the recent 3 months - The InvestChronicle
Tue, 28 Jul 2020
Is Aikido Pharma Inc (AIKI) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver
Fri, 24 Jul 2020
Is Aikido Pharma Inc (AIKI) a Stock to Watch This Week? - InvestorsObserver
Thu, 23 Jul 2020
AIkido Pharma Inc. (AIKI) Quarterly Performance is 44.23%: Here is the Surprise Factor - The InvestChronicle
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqCM |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
35 |
| Shares Float (M) |
27 |
|
% Held by Insiders
|
5.64 |
|
% Held by Institutions
|
17.45 |
|
Shares Short (K)
|
114 |
|
Shares Short P. Month (K)
|
42 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-81900.00 |
|
Return on Assets (ttm)
|
-27.5 |
|
Return on Equity (ttm)
|
-71.2 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-4 |
|
Levered Free Cash Flow (M)
|
-6 |
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
3403.53 |
|
Price to Cash Flow
|
-8.58 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
1980-05-11 |
|
7 Binary Options
|
|
Your Ad Here
|
|
